5 výsledky
FIELD OF THE INVENTION
The present invention relates to compounds for targeting human or animal disease states characterized by aberrant expression of the intermediate filament type III proteins, such as vimentin, methods and compounds for detecting intermediate filament type III proteins, such as
BACKGROUND OF THE INVENTION
Plant-based medicines or drugs are of ancient origin and their use is known in cultures throughout the world. A common concern with herbal medicine is that herbs are slow acting in treating an ailment. Therefore, a movement to identify individual active ingredients in
FIELD
Methods to enhance the bioactivity of Ashwagandha extract is provided. Compositions of Ashwagandha extract enriched with withanolide glycosides and saponins after removing alkaloids, withanolide aglycones and oligosaccharides are disclosed. Processes for manufacturing extracts of Ashwagandha
FIELD
Methods to enhance the bioactivity of Ashwagandha extract is provided. Compositions of Ashwagandha extract enriched with withanolide glycosides and saponins after removing alkaloids, withanolide aglycones and oligosaccharides are disclosed. Processes for manufacturing extracts of Ashwagandha
This Application is a National Phase entry of International Application Serial Number PCT/IN2016/050354 filed Oct. 18, 2016, which claims priority to Indian Application Serial No. IN 5691/CHE/2015, filed Oct. 22, 2015.
FIELD
Methods to enhance the bioactivity of Ashwagandha extract is provided.